Thyroid nodules and differentiated thyroid cancer.

Andrew J Bauer

Journal: Endocrine development 2015;26():183-201

PMID: 25231453

Abstract

The incidence of thyroid nodules and thyroid cancer has increased over the last several decades. This change is influenced by several factors, to include the status of iodine sufficiency, access to the health care system and, perhaps most significantly, the increased use of radiological imaging. Thorough evaluation of a thyroid nodule includes review of the patient's medical and family history, followed by thyroid ultrasound and fine-needle aspiration biopsy. Similar to adults, the majority of nodules in children are benign; however, there is a 3- to 5-fold higher risk that a nodule found in a pediatric patient (≤18 years) will be malignant when compared to an adult. Differentiated thyroid carcinoma (DTC) is the most common malignancy with approximately 90-95% being papillary thyroid carcinoma and the remainder follicular thyroid carcinoma. With proper evaluation and management, the prognosis for pediatric patients with DTC is excellent; however, the risk of treatment complications and recurrence is relatively high. The development of pediatric specific guidelines for the evaluation and management of thyroid nodules and DTC as well as the creation of centers with surgical and medical expertise is crucial in order to optimize care and gain a better understanding of factors that impact disease-specific morbidity.

Address: The Thyroid Center, Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pa., USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.